None
Quote | Orchard Therapeutics plc (NASDAQ:ORTX)
Last: | $16.70 |
---|---|
Change Percent: | 0.3% |
Open: | $16.65 |
Close: | $16.70 |
High: | $16.72 |
Low: | $16.63 |
Volume: | 372,349 |
Last Trade Date Time: | 01/23/2024 03:00:00 am |
News | Orchard Therapeutics plc (NASDAQ:ORTX)
TOKYO, LONDON and BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe, today announced that Bobby Gaspar, M.D., Ph.D., co-founder and chief executive officer, ...
Crescent Energy Company Class A (CRGY) is expected to report $0.21 for Q4 2023 ThredUp Inc. (TDUP) is expected to report $-0.13 for Q4 2023 Wright Investors` Service Holdings Inc (IWSH) is expected to report for Q4 2023 Bridgford Foods Corporation (BRID) is expected to report for Q1 2...
Message Board Posts | Orchard Therapeutics plc (NASDAQ:ORTX)
Subject | By | Source | When |
---|---|---|---|
znewcar1: $ORTX 22% v29,3M c.63 f126,689M H.720 ML.3601 | znewcar1 | investorshangout | 01/06/2023 5:44:45 AM |
Holy volume!! Nice to see life again! Long | 1972 | investorshub | 01/06/2023 1:01:26 AM |
Orchard Therapeutics Announces U.S. FDA Clearance of IND | subslover | investorshub | 01/05/2023 1:51:48 PM |
Just watch .. AF up? | kzivann | investorshub | 12/03/2022 12:03:49 PM |
Again, only a matter of time before ORTX | 1972 | investorshub | 06/11/2022 5:39:12 AM |
News, Short Squeeze, Breakout and More Instantly...
Orchard Therapeutics plc Company Name:
ORTX Stock Symbol:
NASDAQ Market:
Orchard Therapeutics plc Website:
TOKYO, LONDON and BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe, today announced that Bobby Gaspar, M.D., Ph.D., co-founder and chief executive officer, ...
Crescent Energy Company Class A (CRGY) is expected to report $0.21 for Q4 2023 ThredUp Inc. (TDUP) is expected to report $-0.13 for Q4 2023 Wright Investors` Service Holdings Inc (IWSH) is expected to report for Q4 2023 Bridgford Foods Corporation (BRID) is expected to report for Q1 2...
Gene therapy being developed as a one-time treatment to address the underlying cause of the disease by inserting a functional copy of the human IDUA gene into a patient’s own hematopoietic stem cells HURCULES study to enroll 40 patients at clinical sites across the U.S....